Welcome to
Together is a new resource for anyone affected by pediatric cancer - patients and their parents, family members, and friends.
Learn MoreSupportive Care
Complera® is a tablet that contains 3 medicines used to treat infection caused by the human immunodeficiency virus (HIV). The 3 medications are called rilpivirine (Edurant®), emtricitabine (Emtriva®), and tenofovir (Viread®). Rilpivirine belongs to a group of medicines known as nonnucleoside reverse transcriptase inhibitors (NNRTIs). Emtricitabine and tenofovir belong to a group called nucleoside reverse transcriptase inhibitors (NRTIs). Complera® can slow down how soon you will see symptoms of HIV or slow the damage caused by HIV, but it cannot cure HIV infection. Complera® tablets contain 25 mg of rilpivirine, 200 mg emtricitabine, and 300 mg tenofovir.
Symptoms of an allergic reaction include: rash, hives, itching, chills, fever, headache, muscle ache, shortness of breath, coughing, tightness in the throat, swelling of the face or neck.
Not all patients who take Complera® will experience these side effects. Common side effects are bolded, but there may be others. Please report all suspected side effects to your doctor or pharmacist.
Find more information on side effects.
Be sure to discuss all questions and instructions with your doctor or pharmacist.